Showing 401 - 420 results of 1,160 for search '(( significant decrease decrease ) OR ( significant adverse decrease ))~', query time: 0.31s Refine Results
  1. 401

    Costs of treating serious adverse effects of drugs used for treatment of obesity: comparison of selected European countries by Branislava Raičević (20102929)

    Published 2024
    “…<p>Drugs for the treatment of obesity show significant effectiveness, but the adverse effects (ADRs) of these drugs are numerous and varied, and some of them are highly cost-generating. …”
  2. 402

    Table 2_Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.xlsx by Xianyu Dai (18939514)

    Published 2025
    “…The median age among these cases was 65 years, with males comprising 53.4%. There were significant annual increases in UR reports associated with antineoplastic agents (0.19% per year) and antidiabetic drugs (0.09% per year), while reports linked to bronchodilators decreased (−0.53% per year). …”
  3. 403

    Table 1_Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.docx by Xianyu Dai (18939514)

    Published 2025
    “…The median age among these cases was 65 years, with males comprising 53.4%. There were significant annual increases in UR reports associated with antineoplastic agents (0.19% per year) and antidiabetic drugs (0.09% per year), while reports linked to bronchodilators decreased (−0.53% per year). …”
  4. 404

    Findings of the study. by Kalaivanan Syasyila (21430046)

    Published 2025
    “…<div><p>The prevalence of recidivism among individuals with a history of substance use and incarceration remains a significant concern for criminal justice systems worldwide. …”
  5. 405

    PRISMA Flowchart. by Kalaivanan Syasyila (21430046)

    Published 2025
    “…<div><p>The prevalence of recidivism among individuals with a history of substance use and incarceration remains a significant concern for criminal justice systems worldwide. …”
  6. 406

    General description of the study. by Kalaivanan Syasyila (21430046)

    Published 2025
    “…<div><p>The prevalence of recidivism among individuals with a history of substance use and incarceration remains a significant concern for criminal justice systems worldwide. …”
  7. 407

    Quality Assessment. by Kalaivanan Syasyila (21430046)

    Published 2025
    “…<div><p>The prevalence of recidivism among individuals with a history of substance use and incarceration remains a significant concern for criminal justice systems worldwide. …”
  8. 408

    Inclusion and exclusion criteria. by Kalaivanan Syasyila (21430046)

    Published 2025
    “…<div><p>The prevalence of recidivism among individuals with a history of substance use and incarceration remains a significant concern for criminal justice systems worldwide. …”
  9. 409

    Data Sheet 1_Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular disease.docx by Lijia Liu (706103)

    Published 2025
    “…Objective<p>This study aimed to evaluate the effectiveness of levothyroxine, compared to non-levothyroxine treatment, in preventing adverse cardiovascular events and mortality in patients with hypothyroidism and cardiovascular disease (CVD).…”
  10. 410

    DataSheet1_Characteristics of adverse reactions of three anti-glioma drugs in WHO-VigiAccess.ZIP by Huadong Ke (19937268)

    Published 2024
    “…To provide a reference for clinical treatment, we analyzed the similarities and differences in the adverse reactions of the three medications by calculating the proportion of adverse reactions recorded for each drug.…”
  11. 411
  12. 412
  13. 413

    Image 1_Safety assessment of temozolomidee: real-world adverse event analysis from the FAERS database.png by Yu Liu (6938)

    Published 2025
    “…</p>Methods<p>Based on data from the FDA Adverse Event Reporting System (FAERS) database, a retrospective pharmacovigilance study was conducted to evaluate temozolomide-related adverse events. …”
  14. 414

    Summary of study eligibility criteria. by Biban Gill (1473337)

    Published 2025
    “…In addition, a panel of safety blood markers measured pre- and post-intervention confirmed no clinically significant changes in blood chemistry or blood cell count.…”
  15. 415

    Summary of study participation and feasibility. by Biban Gill (1473337)

    Published 2025
    “…In addition, a panel of safety blood markers measured pre- and post-intervention confirmed no clinically significant changes in blood chemistry or blood cell count.…”
  16. 416
  17. 417
  18. 418
  19. 419

    Adverse events in patients with castration-resistant prostate cancer treated with ra-223: a retrospective pharmacovigilance study by Lei Yang (102719)

    Published 2024
    “…</p> <p>This research assesses the side effects of Ra-223 by analyzing reports of adverse events (AEs) from the FDA’s Adverse Event Reporting System (FAERS) database. …”
  20. 420

    Supplementary information–dataset. by Leriana Garcia Reis (12646978)

    Published 2024
    “…Our previous analysis of these mice found HF diet decreased number of pups born, but increased litter growth rate to postnatal (PN) d12. …”